Global calcium gluconate market will register commendable growth over 2022-2028, owing to the escalating product demand from various industries, especially food & beverage and pharmaceutical. Calcium gluconate refers to a calcium salt that is used to replete serum calcium levels directly in cases of calcium deficiency or hypocalcemia. Calcium gluconate is administered either orally or intravenously (IV) in the treatment of hypocalcemia, cardiotoxicity from hyperkalemia or hypermagnesemia, or cardiac arrest.
The growing prevalence of calcium deficiency among the global population is a major factor driving calcium gluconate industry trends over 2022-2028. Over 3.5 million people worldwide are at risk of having a calcium deficiency. Hypocalcemia is associated with several clinical indications, ranging in severity from a few mild symptoms to potentially chronic or life-threatening conditions. This will contribute greatly to calcium gluconate market share since the mineral supplement is used extensively in the treatment of hypocalcemia through intravenous administration.
Nutraceuticals are poised to emerge as a major application segment for the calcium gluconate industry by 2028, given the substantial increase in nutraceutical manufacturing worldwide. In June 2021, the University of Westminster introduced a first-of-its-kind Centre for Nutraceuticals in Europe, built to serve as a catalyst for enhancing human wellbeing and health through innovation and research. The center was launched with high-profile collaboration with elite athletes to create a novel health supplement range under the UNITY brand, designed to help people achieve their performance goals. Factors such as these could augment calcium gluconate market outlook over the estimated timeframe since it is coming to be increasingly considered a key constituent in many calcium-based fitness supplements.
From a regional perspective, the Asia Pacific is set to become a major revenue pocket for the calcium gluconate market. This growth is characterized by a large calcium deficient population, rising health-consciousness among people, and the increasing inclination towards food additives and supplements to meet calcium requirements. Countries like Japan, China, and India are major contributors to regional industry growth. For instance, despite India’s position as the largest milk producer, there is a significant shortage in calcium intake in the country, which manifests in the form of adverse effects on bone health. In order to counteract these conditions, the use of calcium supplements is becoming increasingly prevalent, which could in turn boost calcium gluconate demand in the region.
The competitive and fragmented global calcium gluconate market includes key players such as Mil-Spec Industries Corporation, Noah Technologies Corporation, Spectrum Chemical Manufacturing Corp., AKZO Nobel Chemicals Inc, Alfa Aesar (Thermo Fisher Scientific), and Glucona America, Inc. These entities are focused on various strategies like joint ventures, mergers, and alliances to expand their presence in the global business landscape.
The primary health implications of the ongoing COVID-19 pandemic have manifested mainly in the form of dry cough, fatigue, fever, and respiratory distress. However, in April 2020, a case of severe acute hypocalcemia was recorded in an Italian patient diagnosed with the SARS-CoV-2 infection, which triggered numerous other studies aimed at studying the role of calcium deficiency in COVID-19 cases. Hypocalcemia has been observed to be a highly prevalent biochemical abnormality in coronavirus patients with a prominent negative impact on the severity of the infection, thrombotic markers, biochemical inflammation, and mortality.
Given these observations, the calcium gluconate market share may witness considerable growth over the forecast period, since the mineral supplement plays a major role in the treatment of hypocalcemia. Demand for calcium gluconate will also rise substantially due to the rapid growth in nutraceutical consumption during the COVID-19 pandemic. Heightening awareness regarding health and wellness management among consumers, alongside the emergence of nutraceuticals designed to address conditions ranging from mental health to metabolic disorders to organ failures, post COVID-19, will further promote calcium gluconate usage.